Food and Drug Administration's Role in Dermatology, An Issue of Dermatologic Clinics
Series: The Clinics: Internal Medicine; 40-3;
- Publisher's listprice EUR 95.99
-
39 811 Ft (37 916 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 7 962 Ft off)
- Discounted price 31 849 Ft (30 333 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
39 811 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier Health Sciences
- Date of Publication 27 June 2022
- ISBN 9780323849692
- Binding Hardback
- No. of pages240 pages
- Size 228x152 mm
- Weight 410 g
- Language English 265
Categories
Long description:
In this issue, guest editors bring their considerable expertise to this important topic.
Provides in-depth reviews on the latest updates in the field, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.
Table of Contents:
The History of Dermatology and Dermatologists at the US Food and Drug Administration
The Food and Drug Administration's Role in Dermatologic Drug Development
Postmarket Assessment for Drugs and Biologics Used in Dermatology and Cutaneous Adverse Drug Reactions
How Does the Food and Drug Administration Approve Topical Generic Drugs Applied to the Skin?
Dermatology Drugs for Children-U.S. Food and Drug Administration Perspective
Regulation of Medical Devices for Dermatology
Regulation of Cosmetics in the United States
Cutaneous Pharmacokinetic Approaches to Compare Bioavailability and/or Bioequivalence for Topical Drug Products
Measuring What Matters to Patients in Dermatology Drug Development: A Regulatory Perspective
Inta Ruka: People I know
19 110 HUF
16 244 HUF
Science Year 3
10 032 HUF
8 528 HUF
